Eli Lilly
$144.749876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$144.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.15 (-0.10%) Today
-$0.01 (-0.01%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Eli Lilly and other stocks, options, and ETFs commission-free!
About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN. The listed name for LLY is Eli Lilly & Co.
CEO
David A. Ricks
Employees
33,625
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
138.47B
Price-Earnings Ratio
23.72
Dividend Yield
1.98
Average Volume
3.78M
High Today
$145.34
Low Today
$142.61
Open Price
$145.06
Volume
3.22M
52 Week High
$170.75
52 Week Low
$115.92
Collections
LLY News
ReutersNov 24
Eli Lilly to supply 26,000 doses of COVID-19 antibody drug to Canada
FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
(Reuters)
Analyst Ratings
60%
of 15 ratings
Buy
60%
Hold
40%
Sell
0%
LLY Earnings
$0.00
$0.63
$1.26
$1.89
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Jan 29, Pre-Market
You May Also Like
More LLY News
ReutersNov 20
Canada grants interim authorization to Eli Lilly's COVID-19 antibody drug
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker, in Fegersheim near Strasbourg, France,
